Research
NODS-CoV-2: Simulating risks of hospital-acquired infections via SARS-CoV-2
… from the Anti-infective evasion and pharmacoepidemiology (Université Paris-Saclay, UVSQ, Inserm) and Epidemiology and … public assistance - Paris hospitals (AP-HP), Inserm, UVSQ, Université Paris-Saclay, Institut Pasteur, Université de Bordeaux, Université de Lyon/CIRI, Inria. … …Published on: Tue 26/05/2020 - 08:40